06-11-2025 20:18 via news.google.com

International Biotechnology beats benchmark with 0.7% NAV gain - MarketScreener

International Biotechnology beats benchmark with 0.7% NAV gain  MarketScreener
Read more »

Biotechnology news



Agricultural Microbials Market Analysis and Investment Opportunities, 2025-2032 - Biotechnology Inno - pharmiweb.com
Agricultural Microbials Market Analysis and Investment Opportunities, 2025-2032 - Biotechnology Innovations Drive Growth in Agricultural Microbials, Transforming Agri-Business Strategies - ResearchAndMarkets.com - 01net
Department of Biotechnology (DBT), Government of India, Biotechnology Industry Research Assistance Council (BIRAC), and Coalition for Epidemic Preparedness Innovations (CEPI) sign ‘Engagement Strategy’ for Cooperation on Vaccine Research, Develop - In
iNGENū CRO Identifies How Biotechnology Companies Can Execute Cost-Efficient Clinical Trials in Tough Economic Environments - Reuters
Is Sana Biotechnology's (SANA) SC451 Pivot Quietly Redefining Its Long-Term Platform Strategy? - simplywall.st
SOA to organise 3-day International Conference on Biotechnology in December - prameyanews.com
How a biotechnology degree empowers students to tackle air pollution, water purification - The Hans India
Oklahoma is helping lead the way in biotechnology | Opinion - The Oklahoman
Orano Med and Roche ink clincical distribution deal in radiopharmacy - European Biotechnology Magazine
Sana Biotechnology’s Surging Stock: Buy or Sell? - StocksToTrade
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Major Shareholder Sells 191,854 Shares of Stock - MarketBeat
What’s Driving the U.S. Biotechnology Market Towards USD 2004 Billion by 2034? - BioSpace
Reassessing CureVac (NasdaqGM:CVAC) Valuation After Its Removal From the NASDAQ Biotechnology Index - simplywall.st
Australian start-up Evinco launches with focus on Alzheimer’s - The Pharma Letter
Desktop versie